|
Lidocaine EP Impurity B
|
利多卡因EP雜質(zhì)B
|
2903-45-9
|
|
Ketoprofen Impurity 5
|
酮洛芬雜質(zhì)5
|
59960-32-6
|
|
Labetalol EP Impurity A
|
拉貝洛爾EP雜質(zhì)A
|
1391051-99-2
|
|
Labetalol EP Impurity D
|
拉貝洛爾EP雜質(zhì)D
|
68807-83-0
|
|
Lacosamide Impurity 2
|
拉科酰胺雜質(zhì)2
|
1325220-60-7
|
|
Lidocaine EP Impurity F
|
利多卡因EP雜質(zhì)F
|
142713-08-4
|
|
Levonorgestrel EP Impurity U
|
左炔諾孕酮EP雜質(zhì)U（炔諾酮）
|
68-22-4
|
|
Levodopa EP Impurity D
|
左旋多巴EP雜質(zhì)D
|
5796-17-8
|
|
Lenvatinib Impurity 12
|
樂伐替尼雜質(zhì)12
|
2250242-56-7
|
|
Lacosamide Related Compound B
|
拉科酰胺 相關(guān)化合物 B
|
1822463-67-1
|
|
Lacosamide EP Impurity I
|
拉科酰胺EP雜質(zhì)I
|
2295925-90-3
|
|
Levofloxacin EP Impurity B
|
左氧氟沙星EP雜質(zhì)B
|
117707-40-1
|
|
Lombartinib impurity
|
侖伐替尼雜質(zhì)
|
417716-92-8
|
|
Lombartinib impurity 8
|
侖伐替尼雜質(zhì)8
|
417724-81-3
|
|
Valsartan Impurity 8(Irbesartan Impurity 26)
|
纈沙坦雜質(zhì)8(厄貝沙坦雜質(zhì)26)
|
152708-24-2
|
|
Latamoxef Impurity C
|
拉氧頭孢雜質(zhì)C
|
75007-70-4
|
|
Lidocaine EP Impurity J
|
利多卡因EP雜質(zhì)J
|
857570-37-7
|
|
Levocarnitine Impurity 10
|
左卡尼汀雜質(zhì)10
|
105-33-9
|
|
Labetalol Impurity 12
|
拉貝洛爾雜質(zhì)12
|
32780-65-7
|
|
Losartan Potassium
|
氯沙坦鉀
|
124750-99-8
|
|
Latamoxef Impurity 2
|
拉氧頭孢雜質(zhì)2
|
105-13-5
|
|
Ketoprofen Tromethamine Amide
|
酮洛芬氨丁三醇酰胺（酮洛芬雜質(zhì)32）
|
1777830-05-3
|
|
Lacosamide EP Impurity G
|
拉科酰胺EP雜質(zhì)G
|
588-46-5
|
|
Ketoprofen Methyl Ester
|
酮洛芬甲酯（酮洛芬雜質(zhì)9）
|
47087-07-0
|
|
Lidocaine EP Impurity C
|
利多卡因EP雜質(zhì)C
|
2198-53-0
|
|
Losartan N-Trithyl Impurity
|
氯沙坦 N-三苯甲基雜質(zhì)（氯沙坦雜質(zhì)35）
|
124751-00-4
|
|
Losartan EP Impurity J
|
氯沙坦EP雜質(zhì)J
|
1006062-27-6
|
|
Ketoprofen EP Impurity H
|
酮洛芬EP雜質(zhì)H
|
5689-33-8
|
|
Levodopa
|
左旋多巴
|
59-92-7
|
|
Loratadine Impurity7
|
氯雷他定雜質(zhì)7
|
38089-93-9
|
|
Irbesartan Impurity 20
|
厄貝沙坦雜質(zhì)20
|
143618-44-4
|
|
Levocarnitine Impurity 6
|
左卡尼汀雜質(zhì)6
|
2788-28-5
|
|
Loperamide EP Impurity G
|
洛哌丁胺EP雜質(zhì)G
|
109572-89-6
|
|
Levocarnitine EP Impurity C Chloride
|
左卡尼汀EP雜質(zhì)C
|
6490-20-6
|
|
Lacosamide EP Impurity C
|
拉科酰胺EP雜質(zhì)C
|
1318777-56-8
|
|
Ketoprofen
|
酮洛芬
|
22071-15-4
|
|
Olmesartan Medoxomil Impurity 25（Losartan Impurity 7）
|
奧美沙坦酯雜質(zhì)25（氯沙坦雜質(zhì)7）
|
358685-13-9
|
|
Levodopa EP Impurity A
|
左旋多巴EP雜質(zhì)A
|
27244-64-0
|
|
Lacosamide EP Impurity H
|
拉科酰胺EP雜質(zhì)H
|
1375090-19-9
|
|
Lacosamide
|
拉科酰胺
|
175481-36-4
|
|
Levonorgestrel EP Impurity B
|
左炔諾孕酮EP雜質(zhì)B
|
19914-67-1
|
|
Losartan EP Impurity D
|
氯沙坦EP雜質(zhì)D
|
83857-96-9
|
|
Lidocaine Dichloro Impurity
|
利多卡因二氯雜質(zhì)
|
39084-88-3
|
|
Leuprorelin EP Impurity C
|
亮丙瑞林EP雜質(zhì)C
|
54785-87-4
|
|
Loxoprofen Impurity 14
|
洛索洛芬雜質(zhì)14
|
81762-82-5
|
|
Ketorolac Impurity 17
|
酮咯酸雜質(zhì)17
|
142231-06-9
|
|
Levonorgestrel EP Impurity L
|
左炔諾孕酮EP雜質(zhì)L
|
21800-83-9
|
|
Lacosamide EP Impurity J
|
拉科酰胺EP雜質(zhì)J
|
100-46-9
|
|
Dexketoprofen tromethamine
|
右酮洛芬氨丁三醇
|
156604-79-4
|
|
Loratadine Impurity8
|
氯雷他定雜質(zhì)8
|
133330-60-6
|
|
Levonorgestrel EP Impurity M
|
左炔諾孕酮EP雜質(zhì)M
|
51087-61-7
|
|
Levonorgestrel EP Impurity K
|
左炔諾孕酮EP雜質(zhì)K
|
793-55-5
|
|
Lacosamide EP Impurity E
|
拉科酰胺EP雜質(zhì)E
|
175481-39-7
|
|
Lacosamide EP Impurity K
|
拉科酰胺EP雜質(zhì)K
|
86921-49-5
|
|
Lidocaine EP Impurity G
|
利多卡因EP雜質(zhì)G
|
42459-30-3
|
|
Ketoprofen EP Impurity L
|
酮洛芬EP雜質(zhì)L
|
1797984-80-5
|
|
Lenvatinib Impurity 53
|
樂伐替尼雜質(zhì)53
|
2143930-76-9
|
|
Levonorgestrel EP Impurity T
|
左炔諾孕酮EP雜質(zhì)T
|
799-43-9
|
|
Lansoprazole Impurity A
|
蘭索拉唑雜質(zhì)A
|
213476-12-1
|
|
Lidocaine Impurity 11
|
利多卡因雜質(zhì)11
|
1135231-62-7
|
|
NorKetotifen Hydrogen Fumarate
|
去甲酮替芬富馬酸氫鹽
|
930765-16-5
|
|
Ketoprofen Impurity 4
|
酮洛芬雜質(zhì)4
|
643-65-2
|
|
Ketoprofen Impurity 15
|
酮洛芬雜質(zhì)15
|
1257296-76-6
|
|
Levodopa EP Impurity C
|
左旋多巴EP雜質(zhì)C
|
7636-26-2
|
|
Levonorgestrel
|
左炔諾孕酮
|
797-63-7
|
|
Lidocaine EP Impurity D
|
利多卡因EP雜質(zhì)D
|
7728-40-7
|
|
Leuprorelin Acetate
|
醋酸亮丙瑞林
|
74381-53-6
|
|
Lidocaine EP Impurity K
|
利多卡因EP雜質(zhì)K
|
50295-20-0
|
|
Labetalol EP Impurity B
|
拉貝洛爾EP雜質(zhì)B
|
802620-01-5
|
|
Ketoprofen Impurity 25
|
酮洛芬雜質(zhì)25
|
872091-00-4
|
|
Losartan Dibromo N2-Trityl Impurity
|
氯沙坦二溴N2-三苯基雜質(zhì)（氯沙坦雜質(zhì)37）
|
151052-34-5
|
|
Lidocaine EP Impurity I
|
利多卡因EP雜質(zhì)I
|
17289-53-1
|
|
Ketoprofen EP Impurity G
|
酮洛芬EP雜質(zhì)G
|
5537-71-3
|
|
Ketoprofen EP Impurity J
|
酮洛芬EP雜質(zhì)J
|
1785759-59-2
|
|
Levofloxacin EP Impurity F
|
左氧氟沙星EP雜質(zhì)F
|
100986-89-8
|
|
Ketorolac Impurity 31
|
酮咯酸雜質(zhì)31
|
144710-35-0
|
|
Losartan
|
氯沙坦
|
114798-26-4
|
|
Levodopa Related Compound 1
|
左旋多巴相關(guān)化合物1
|
32161-30-1
|
|
Lacosamide EP Impurity A
|
拉科酰胺EP雜質(zhì)A
|
175481-37-5
|
|
Losartan Carboxylic Acid-D4
|
氯沙坦羧酸-D4（氯沙坦雜質(zhì)29）
|
1246820-62-1
|
|
Lenvatinib Impurity 56
|
樂伐替尼雜質(zhì)56
|
796848-79-8
|
|
Levocarnitine EP Impurity D
|
左卡尼汀EP雜質(zhì)D
|
857162-57-3
|
|
Lacosamide EP Impurity B
|
拉科酰胺EP雜質(zhì)B
|
1318777-54-6
|
|
Levofloxacin Impurity Y
|
左氧氟沙星雜質(zhì)Y
|
103995-33-1
|
|
Lidocaine EP impurity a (ropivacaine EP impurity h) (bupivacaine EP impurity f)
|
利多卡因EP雜質(zhì)A(羅哌卡因EP雜質(zhì)H)（布比卡因EP雜質(zhì)F）、2,6-二甲基苯胺（對照品）
|
87-62-7
|
|
(S)-Ketoprofen
|
(S)-酮洛芬（酮洛芬雜質(zhì)3）
|
22161-81-5
|
|
Labetalol EP Impurity C
|
拉貝洛爾EP雜質(zhì)C
|
2386661-13-6
|
|
Lenvatinib Impurity 54
|
樂伐替尼雜質(zhì)54
|
2143930-77-0
|
|
Losartan EP Impurity E(Valsartan Impurity S)
|
氯沙坦EP雜質(zhì)E(纈沙坦雜質(zhì)S)
|
120568-11-8
|
|
Lansoprazole Impurity 16
|
蘭索拉唑雜質(zhì)16
|
59886-90-7
|
|
Lacosamide EP Impurity D
|
拉科酰胺EP雜質(zhì)D
|
196601-69-1
|
|
Lacosamide EP Impurity F
|
拉科酰胺EP雜質(zhì)F
|
175481-38-6
|
|
Lidocaine EP Impurity E
|
利多卡因EP雜質(zhì)E
|
745798-07-6
|
|
Loxoprofen Impurity 21
|
洛索洛芬雜質(zhì)21
|
492-37-5
|
|
Ketoprofen EP Impurity I
|
酮洛芬EP雜質(zhì)I
|
21288-34-6
|
|
Labetalol Impurity 9
|
拉貝洛爾雜質(zhì)9
|
33254-88-5
|
|
Lenvatinib Impurity 55
|
樂伐替尼雜質(zhì)55
|
2613141-84-5
|
|
Losartan Impurity 21
|
氯沙坦雜質(zhì)21
|
727718-93-6
|
|
Lacosamide Impurity 15
|
拉科酰胺雜質(zhì)15（拉考沙胺雜質(zhì)1）
|
171623-02-2
|
|
Labetalol EP Impurity F
|
拉貝洛爾EP雜質(zhì)F
|
85665-85-6
|